HeimNVAX • BMV
add
Novavax Inc
Við síðustu lokun
205,07 $
Dagbil
202,89 $ - 210,99 $
Árabil
65,10 $ - 390,00 $
Markaðsvirði
1,63 ma. USD
Meðalmagn
3,22 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
NASDAQ
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 415,48 m. | -2,11% |
Rekstrarkostnaður | 101,00 m. | 22,84% |
Nettótekjur | 162,38 m. | 179,93% |
Hagnaðarhlutfall | 39,08 | 185,88% |
Hagnaður á hvern hlut | 0,99 | 70,69% |
EBITDA | 173,23 m. | 115,93% |
Virkt skatthlutfall | 1,34% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 1,05 ma. | 107,47% |
Heildareignir | 1,82 ma. | 7,93% |
Heildarskuldir | 2,25 ma. | -7,76% |
Eigið fé alls | -431,71 m. | — |
Útistandandi hlutabréf | 160,09 m. | — |
Eiginfjárgengi | -75,95 | — |
Arðsemi eigna | 25,55% | — |
Ávöxtun eigin fjár | -104,69% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 162,38 m. | 179,93% |
Handbært fé frá rekstri | 314,27 m. | 282,78% |
Reiðufé frá fjárfestingum | -372,71 m. | -4.691,19% |
Reiðufé frá fjármögnun | 258,22 m. | 320,99% |
Breyting á handbæru fé | 199,62 m. | 267,75% |
Frjálst peningaflæði | 563,88 m. | 205,71% |
Um
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus, as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19.
The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end of 2021, and in Canada in February 2022, as the fifth vaccine against COVID-19, following Pfizer/BioNTech, Moderna, Janssen and AstraZeneca. Wikipedia
Framkvæmdastjóri
Stofnsett
1987
Höfuðstöðvar
Vefsvæði
Starfsfólk
1.543
